Pros | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | 5Y returns in the top 25% of the category. 3Y returns in the top 25% of the category. Among most bought funds within the category. | ||
Cons | 3Y returns in the bottom 25% of the category. | - |
INDMoney rank | 6/8 | 1/8 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 13 Years 3 Months | 7 Years 8 Months | ||
Fund AUM | ₹7875 Cr | ₹6658 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 0.92% | 1.02% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 39 | 42 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 1 | 2 | ||
Top 3 Sectors | Health (100%) |
| ||
Equity % | 97.37% | 97.87% | ||
Debt % | - | - | ||
P/E | 34.75 | 31.1 | ||
P/B | 5.37 | 3.84 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -0.97% | -3.58% | ||
3-Month Return | -2.66% | -6.72% | ||
6-Month Return | -2.59% | -5.58% | ||
1-Year Return | 6.75% | 4.81% | ||
3-Year Return | 23.43% | 27.26% | ||
5-Year Return | 15.68% | 17.45% |
Sharpe | 0.97 | 1.19 | ||
Alpha | 0.33 | 3.82 | ||
Beta | 0.9 | 0.95 | ||
Standard Deviation | 15.32 | 16.02 | ||
Information Ratio | -0.32 | 1.23 |
Description | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Sailesh Raj Bhan, Lokesh Maru, Kinjal Desai, Divya Sharma | Dharmesh Kakkad, Sharmila D’mello |